Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma

Clinical trial NCT03374488 · COMPLETED

Trial details

NCT number: NCT03374488
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

UC (Urothelial Cancer)

Start date: 2017-12-22
Primary completion: 2018-07-27
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.